Related Experiment Video
Updated: Jun 25, 2026

Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
Physicochemical characterization of siRNA-peptide complexes
Maggie Law1, Mousa Jafari, P Chen
1Dept. of Chemical Engineering, University of Waterloo, Waterloo, ON, Canada N2L 3G1.
Arginine-9 peptide effectively complexes with short interfering RNA (siRNA) to enhance stability and cellular uptake for potential breast cancer therapy. This study characterizes these siRNA-peptide complexes for improved drug delivery.
Area of Science:
- Biochemistry
- Molecular Biology
- Nanotechnology
Background:
- Short interfering RNAs (siRNAs) are crucial for RNA interference (RNAi) but suffer from poor stability and low cellular uptake.
- Effective delivery carriers are needed to overcome siRNA degradation and improve transfection efficiency for therapeutic applications.
Purpose of the Study:
- To investigate Arginine-9 (R9), a cell-penetrating peptide, as a carrier for connective tissue growth factor (CTGF) siRNA.
- To characterize the physicochemical properties of siRNA-R9 complexes for potential breast cancer treatment.
Main Methods:
- Complexation and interaction studies using UV/vis spectroscopy and circular dichroism (CD).
- Characterization of complex size and surface charge via dynamic light scattering (DLS) and Zeta potential measurements.
- Assessment of salt effects on complex properties using UV/vis spectroscopy.
Main Results:
- siRNA and R9 readily formed stable complexes/aggregates.
- Complex surface charge changed with increasing peptide concentration, reaching a maximum hydrodynamic diameter of approximately 1 µm.
- Binding ratios of R9 to siRNA were determined using spectroscopy and light scattering techniques.
Conclusions:
- Physicochemical characterization provides a basis for controlling siRNA-peptide complex properties.
- R9 shows potential as a carrier for siRNA therapeutics, improving stability and delivery.
- This research supports the development of peptide-based siRNA delivery systems for cancer therapy.
More Related Videos
09:04Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
Published on: September 21, 2017
09:09Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery
Published on: May 2, 2019